We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC4XD.L Share News (C4XD)

  • There is currently no data for C4XD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: Woodford Trust Up 30% As Schroders Tapped

Thu, 24th Oct 2019 10:31

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.

----------

FTSE 100 - WINNERS

----------

RELX, up 3.4%. The business publisher and analytics firm reaffirmed 2019 guidance after a solid first nine months of the year. RELX delivered 4% underlying revenue growth for the first nine months of 2019, with all four business areas delivering an improvement year-on-year. "The full-year outlook is unchanged. As we enter the final quarter of 2019 key business trends are in line with the full year 2018. We remain confident that, by continuing to execute on our strategy, we will deliver another year of underlying growth in revenue and in adjusted operating profit, together with growth in adjusted earnings per share on a constant currency basis in 2019," said RELX.

----------

AstraZeneca, up 3.2%. The pharma giant posted a dip in third-quarter profit as a result of research & development expenses, but did upgrade annual sales guidance. For the three months ended September, pretax profit was USD409 million, down 14%. This reduction was the result of a 32% rise in selling, general & administrative costs, on top of a 5.5% jump in research & development expense. Total revenue rose 20%, reaching USD6.41 billion thanks both to a 16% rise in product sales and to a more than trebling of collaboration revenue. Astra has upgraded product sales guidance for 2019 and is now expecting a low to mid-teens percentage rise, having previously expected a low double-digit percentage increase. Astra also reiterated guidance for core earnings per share of between USD3.50 and USD3.70 for 2019 as a whole.

----------

AVEVA Group, up 2.2%. The engineering and industrial software firm said strong sales execution has led to solid revenue growth. AVEVA achieved low double-digit revenue growth on a proforma constant-currency basis in the financial first half ended September. On a reported basis, revenue benefited from foreign exchange movements, the company said. The revenue mix was "positive", said AVEVA, with every region delivering growth. Rental & Subscription was "very strong", partly offset by expected lower revenue in the Initial & Perpetual Licences and Services units.

----------

FTSE 100 - LOSERS

----------

Royal Bank of Scotland, down 2.2%. In the three months to September 30, RBS recorded an operating pretax loss of GBP8 million compared to a GBP961 million profit a year before. The loss was attributed to a GBP900 million PPI provision. The bank's loss attributable to shareholders totalled GBP315 million, compared to a GBP448 million profit in the third quarter last year and a GBP1.33 billion profit in the second quarter of this year. Net interest income declined 6.5% to GBP2.01 billion from GBP2.15 billion. RBS said its group was hurt from a "particularly challenging" quarter from investment bank NatWest Markets.

----------

FTSE 250 - WINNERS

----------

KAZ Minerals, up 6.2%. The miner expects to beat gold guidance for 2019 after a "record" third quarter of the year. KAZ has previously guided for 2019 gold production between 170,000 ounces and 185,000 ounces. However, it now expects to beat the top end of that range by 5%. This comes after third-quarter gold production of 58,500 ounces for the three months to September, 32% higher than the quarter before. Copper production was 82,900 tonnes, 6.8% higher than the prior three months. KAZ said the rises in production came after strong performances from the Aktogay mine in eastern Kazakhstan and the Bozshakol mine in the north of the country.

----------

FTSE 250 - LOSERS

----------

RHI Magnesita, down 4.4%. The refractory products firm warned a continued deterioration in steel-sector sales volumes are hurting earnings. As a result, RHI Magnesita is predicting 2019 adjusted earnings before interest, tax, and amortisation to be between EUR400 million and EUR410 million, down from the EUR428.1 million recorded in 2018. The Vienna, Austria-headquartered company said Steel revenue for the three months to September 30 has fallen 14% year-on-year and a materially lower contribution from the Steel unit in the second half against the first half is now expected. The global steel market has weakened further and, as a result, customers have significantly reduced their refractory products inventories, RHI Magnesita explained.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

Woodford Patient Capital Trust, up 30%. The firm has appointed Schroder Investment Management as its new portfolio manager, following the exit of star fund manager Neil Woodford last week. Schroder Investment Management, part of FTSE 100 listed asset manager Schroders, will take over as portfolio manager by the end of 2019, when the trust will be renamed Schroder UK Public Private Trust.

----------

Petro Matad, up 76%. The Mongolian oil explorer reported positive results from testing of the Heron-1 well. A first test was performed over a three metre zone at 2,872 metres and indicated an oil column height of at least 70 metres in the Heron-1 well. The second drill stem test was performed over a 12 metre interval from 2,834 metres, with oil and some associated gas flowing to surface without the need for any artificial lift. The peak production recorded during the test was 821 barrels of oil per day and, for the main flow period, the well flowed at an average rate of 200 barrels a day. The company said the Heron-1 flow rate was very encouraging and could indicate a "too conservative" recovery estimate for the Heron structure, however more wells would be required to prove the total volumes in the structure.

----------

Motif Bio, up 23%. The biopharmaceutical firm is to team up with a US Army-funded research institute to evaluate the use of iclaprim in administering antibiotics.

----------

Eurasia Mining, up 32%. The firm said two of the largest investment banks in Russia and China have expressed interest in the company's assets, with talks over their future ongoing.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

C4X Discovery, down 57%. The firm is to raise GBP5.5 million by placing shares at 15 pence each, and also offer 1 share per 9 existing in an open offer to raise a further GBP1.0 million. C4X will use the funds to strengthen the balance sheet and expands the portfolio.

----------

Mobile Streams, down 31%. The firm continues to seek a new nominated advisor, but will not make the October 28 deadline when shares will be suspended if it has not done so. After that, it has a month to get a new nomad, or it will be removed from the London Stock Exchange.

----------

Distil, down 20%. The alcoholic drinks maker swung to a loss in the first half with the company citing tough conditions in the UK unflavoured gin market. The company, which owns the RedLeg rum brand, Blackwood's gin and Blavod vodka, swung to a first half pretax loss of GBP1,000 in the six months to September 30. Last year, it made a GBP101,000 pretax profit. Revenue fell by 29% year-on-year to GBP824,000 from GBP1.2 million. For the full-year Distil expects revenue to lag behind market forecasts, though the company expects operating profit to be in line due to cost control measures.

----------

By George Collard; georgecollard@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
25 Apr 2024 20:57

TRADING UPDATES: Norcros sells Johnson Tiles UK; Trifast trading well

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
15 Apr 2024 14:17

IN BRIEF: C4X Discovery shareholders approve of taking firm private

C4X Discovery Holdings PLC - Manchester, England-based drug discovery company - Shareholders pass all resolutions at general meeting, including resolution one: to cancel the admission of shares to trading on AIM in London, effective from the opening bell on Friday next week. Resolution one passes with 93% voting in favour and 6.9% voting against. Resolution two passes by a similar margin, meaning shareholders approve of C4X re-registering as a private limited company with the name C4X Discovery Holdings Ltd. This is expected to take place in the week beginning April 29.

Read more
8 Apr 2024 14:26

UK shareholder meetings calendar - next 7 days

Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
Friday 12 April 
SigmaRoc PLCAGM
Monday 15 April 
C4X Discovery Holdings PLCGM re re-registering as private limited company
i3 Energy PLCGM re proposed capital reduction
Molecular Energies PLCGM re delisting
Vanquis Banking Group PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
16 Jan 2024 15:27

UK shareholder meetings calendar - next 7 days

Wednesday 17 January 
City Pub Group PLCGM re recommended cash acquisition by Young & Co's Brewery PLC
Diploma PLCAGM
Forward Partners Group PLCGM re takeover offer from Molten Ventures PLC
Impellam Group PLCGM re acquisition by Headfirst Global
Kazera Global PLCAGM
Majedie Investments PLCAGM
Orcadian Energy PLCAGM
Thursday 18 January 
Baillie Gifford European Growth Trust PLCAGM
J Smart & Co (Contractors) PLCAGM
tinyBuild IncGM re fundraise
Topps Tiles PLCAGM
Friday 19 January 
Cardiff Property PLCAGM
Character Group PLCAGM
Focusrite PLCAGM
Substrate Artificial Inteligence SAGM re investment agreement and issue of equity
Monday 22 January 
Highcroft Investments PLCGM re de-listing from LSE and relisting on TISE
Smart Metering Systems PLCGM & court meeting re takeover by funds advised by KKR
Tuesday 23 January 
C4X Discovery Holdings PLCAGM
Marston's PLCAGM
Mitchells & Butlers PLCAGM
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
3 Jan 2024 07:12

C4X Discovery receives $11m from AstraZeneca for COPD drug progress

(Sharecast News) - C4X Discovery, the AIM-listed drug discovery company, has received a "milestone payment" of $11m from biopharma giant AstraZeneca as part of the progress of its NRF2 Activator programme, causing shares to jump by nearly a half on Wednesday.

Read more
14 Dec 2023 11:25

C4X Discovery shares topple 10% as loss widens on higher costs

(Alliance News) - C4X Discovery Holdings PLC on Thursday reported a wider annual loss as costs rose and revenue fell.

Read more
7 Dec 2023 14:32

UK earnings, trading statements calendar - next 7 days

Friday 8 December 
Berkeley Group Holdings PLCHalf Year Results
Monday 11 December 
Begbies Traynor Group PLCHalf Year Results
Tuesday 12 December 
Chemring Group PLCFull Year Results
FRP Advisory Group PLCHalf Year Results
Gelion PLCFull Year Results
RWS Holdings PLCFull Year Results
Sosandar PLCHalf Year Results
Vianet Group PLCHalf Year Results
Wednesday 13 December 
Cohort PLCHalf Year Results
Thursday 14 December 
Balfour Beatty PLCTrading Statement
Bunzl PLCTrading Statement
C4X Discovery Holdings PLCFull Year Results
Capita PLCTrading Statement
Currys PLCFull Year Results
Gore Street Energy Storage Fund PLCHalf Year Results
IntegraFin Holdings PLCFull Year Results
Serco Group PLCTrading Statement
SThree PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
1 Aug 2023 17:39

TRADING UPDATES: C4X Discovery inks Indivior deal, Digitalbox expands

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.